The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Pharmacokinetics (PK) of epacadostat in combination with sirolimus in advanced malignancy.
 
Chao Hui Huang
Stock and Other Ownership Interests - Vanguard Health Care; Vanguard Health Care (I)
Consulting or Advisory Role - DAVA Oncology
Speakers' Bureau - MJH Healthcare Holdings, LLC
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Incyte (Inst); Janssen (Inst); Novartis (Inst); Pfizer (Inst); RRX (Inst); Sanofi (Inst)
 
Takefumi Komiya
Consulting or Advisory Role - Guardant Health; Novocure; Regeneron
Research Funding - Gilead Sciences (Inst); Merck (Inst)
 
Anup Kasi
Consulting or Advisory Role - Ipsen
Research Funding - Ability Pharma (Inst); Astellas Pharma (Inst); Bavarian Nordic (Inst); Cardiff Oncology (Inst); Cend Therapeutics (Inst); FibroGen (Inst); Geistlich Pharma (Inst); Novocure (Inst); Rafael Pharmaceuticals (Inst); TESARO (Inst)
 
Stephen K. Williamson
Stock and Other Ownership Interests - Horizon Therapeutics; Iovance Biotherapeutics; Merus
Research Funding - Acceleron Pharma (Inst); Aleon Pharma (Inst); Astellas Pharma (Inst); Bayer Health (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); EMD Serono (Inst); Merck Serono (Inst); Nektar (Inst); Novartis (Inst); Pharmacyclics (Inst); Regeneron (Inst); Rogosin Institute (Inst); Sanofi (Inst); Seagen (Inst); Sotio (Inst)
 
Scott James Weir
No Relationships to Disclose
 
Joaquina Celebre Baranda
Stock and Other Ownership Interests - Aprea Therapeutics; Forty Seven; Hylapharm; Merus NV; Moderna Therapeutics; MorphoSys; Zymeworks
Consulting or Advisory Role - Sanofi (Inst)
Research Funding - Astellas Pharma (Inst); Exelixis (Inst); Incyte (Inst); Lilly (Inst); Nektar (Inst); Pfizer (Inst); Regeneron (Inst); Sanofi (Inst); Tolero Pharmaceuticals (Inst); Xencor (Inst)